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ABSTRACT 
Cells in our body are under the constant influence of intrinsic and extrinsic factors that 
modulate their behavior. Early on, starting during the development of the organism, growth 
factors, nutrients, oxygen, the extracellular matrix and contact with other cells affect essential 
processes such as proliferation, migration, differentiation and apoptosis. Later on, the same 
types of stimuli regulate tissue homeostasis and play important roles in disease onset. 
Although our understanding of the cellular microenvironment and its impact on the cells is 
deeper than ever before, we still do not fully understand the whole complexity behind it, 
making the need to not only study the microenvironment but also replicate it in vitro more 
pressing. Areas such as tissue engineering, disease modeling, drug testing and in vitro 
microphysiological systems are just some examples where new knowledge and tools in this 
field are necessary for progress.  
This thesis reflects the path I took to first study and then to recreate some of the aspects of 
the neural microenvironment. Paper I is a study of the redox sensing co-repressor CtBP2. 
This protein is well known to integrate oxygen levels and regulate gene expression during 
development and disease. When knocked down in the mouse embryonic brain, normal cortex 
formation was disrupted, revealing an important role of CtBP2 in neural stem cell 
maintenance, differentiation, and migration. In Paper II, we focused on CtBP2 at the 
molecular level, studying it in vitro in rat neural stem cells (NSCs). By applying different 
metabolic conditions in vitro, we showed that hypoxia and 2-Deoxy-D-glucose increased 
acetylation of CtBP2 in proliferating NSCs. Additionally, 1% oxygen treatment resulted in 
altered homodimerization of CtBP2 showing that some aspects of the NSC environment are 
conveyed to post-translational modifications of CtBP2, an important step in its functional 
regulation.  
Paper III explores the use of 3D bioprinting technology and a special material deposition 
technique – freeform reversible embedding of suspended hydrogels (FRESH) – to generate 
a relevant microenvironment for human neuroblastoma 3D cell culture. Using a Parameter 
Optimization Index (POI), we optimized sodium alginate (SA) printing parameters including 
extrusion pressure and speed. With this approach, we successfully printed human 
neuroblastoma cells in 3D encapsulated in SA, maintaining good cell viability and high print 
quality.  
Lastly, to find a more robust biomaterial for the in vitro microenvironment engineering for 
human neuroepithelial-like stem cells (NESCs), in Paper IV we investigated the 
cytocompatibility of these cells with vitronectin-modified recombinant spider silk (VN-
NT2RepCT). Our study showed the necessity of spider silk functionalization with vitronectin 
to provide attachment for NESCs. This material successfully supported neural stem cell 
growth and proliferation, and further analysis of the morphology of focal adhesions revealed 
differences in cell attachment compared to control substrates. Our results suggest potential 
applications for the VN-NT2RepCT in tissue engineering, possibly including 3D bioprinting.    
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1 INTRODUCTION 
1.1 CORTICAL DEVELOPMENT 
The cerebral cortex is composed of two main types of neurons: excitatory glutamatergic 
pyramidal neurons and inhibitory GABAergic interneurons releasing the neurotransmitter 
gamma-aminobutyric acid (GABA). Pyramidal cells constitute approximately 80% of all 
cortical neurons and establish local connections between cortical areas as well as project to 
other subcortical regions [1]. They originate in the proliferative ventricular zone of the dorsal 
telencephalon and migrate radially to the cortical plate forming different cortical layers [2]. 
GABAergic neurons, on the other hand, are a group of cells that originate in ganglionic 
eminence and migrate tangentially to occupy specific layers and establish local circuits in the 
cortex [3,4].  
The development of the cerebral cortex is initiated with the closure of the neural tube at 
embryonic day (E) 10 in mouse and E26-28 in human when dividing neuroepithelial cells 
(NECs) form the ventricular zone (VZ) (see Figure 1 for the visualization of cortex 
development from this point). Initially a series of symmetrical divisions of NECs increases 
the thickness of the VZ expanding stem cell pool. Neurogenesis starts when NECs begin 
asymmetric divisions giving rise to one progenitor and one post-mitotic cell that eventually  
differentiates into either neuronal or glial cell [5,6]. The progenitor cells generated by NECs 
called radial glial cells (RGC) have the characteristic morphology of apical and basal 
processes that extend between the ventricular and pial surface and commonly display Nestin, 
PAX6, and RC2 among other marker proteins [7]. Initially RGCs undergo asymmetric 
divisions generating a projection neuron and another RGC in a process termed direct 
neurogenesis.  
Over time, RGCs give rise to intermediate progenitors (IPs) that start to accumulate above 
the VZ creating a subventricular zone (SVZ) [8,9]. These progenitor cells express among 
others TBR2, CUX1, and CUX2 [10,11]. Most IPs will follow symmetrical division giving 
rise to two neurons [12]. The first generated neurons start forming the preplate. Later, more 
neurons start migrating forming cortical layers in an inside-out fashion, from deep layers 
(DL, V-VI) occupied by earliest-born neurons to upper layers (UL, II-IV) constituted of late-
born neurons. Neurons from layers V-VI express transcription factors such as CTIP2 
(BLC11B) and TBR1 [13–15] whereas neurons from layers II-III typically express CUX1/2, 
BRN1/2 and SATB2 [11,16,17]. Cortical neurogenesis finishes during prenatal development 
(E18.5 in mouse, embryonic week 27 in human) with subsequent gliogenesis taking place 
shortly after birth [18].  
 
  
 
Figure 1. Schematic representation of mouse neocortical development. Reproduced from Kwan et al. (2012) with 
permission from the Company of Biologists. Early during neural development, the progenitor pool is expanded by neural 
progenitors (NPs) by symmetric divisions in the ventricular zone (VZ). In their cell cycle, NPs undergo interkinetic nuclear 
migration (IKNM) when the nucleus moves between the apical and basal surface. At E11.5, NPs start dividing 
asymmetrically, generating neurons which start to migrate upwards guided by radial glia cells (RGC). The preplate (PP) is 
formed by the arrival of the first projection neurons, the first step in the development of the cortical plate (CP). The PP is 
later divided into the marginal zone (MZ) and the subplate (SP) by more neurons migrating to the area. NPs continue 
asymmetric divisions generating neurons for different layers of the forming CP: SP first, then deep layers (L6, L5) and 
upper layers (L4, L3 and L2). The migration of neurons is realized in an inside-out fashion with newborn neurons migrating 
through layers of older neurons.  In the same time, some of the cells from NPs divisions form intermediate progenitor cells 
(IPCs), migrating to the SVZ where they divide symmetrically contributing to the upper layer neurons. Around E17.5, 
gliogenesis starts by NPs generating astrocytes (Ast) in the cortex and subependymal zone (SEZ) and also forming a new 
layer of ependymal cells (EL). BV, blood vessel; CR, Cajal-Retzius cell; DL Pyr, deep-layer pyramidal neuron; IZ, 
intermediate zone; UL Pyr, upper-layer pyramidal neuron; WM, white matter. 
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Birth-dating experiments conducted in mice and monkeys showed a specific order of neuron 
appearance in different cortical layers [19,20] and thereby demonstrated the spatio-temporal 
dependence of cortical layer formation [21,22]. The process of generating the six cortical 
layers composed of specific subtypes of differentiated neurons, astrocytes, and 
oligodendrocytes is regulated by a combination of extrinsic and intrinsic factors, such as 
growth factors and gene expression regulation pathways [18].  
The initially formed preplate constitute mainly of Cajal-Retzius (CR) cells which play an 
important role in lamination of the cerebral cortex [23]. The next step in corticogenesis is the 
switch from CR cells to layer V-VI neurons, achieved by the suppression of CR cell fate and 
redirection towards DL neuron identity. Further neocortical neuron specification requires 
cross-regulatory determination of layer-specific subtype of cells through cell-specific 
transcription factors [24].  
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For DL neurons, factors such as SOX5, TBR1, and CTIP2 play a key role in differentiation 
and cell migration [13,14]. For example, in this interplay between transcription factors, SOX5 
represses Ctip2 expression in layer VI refining its layer V enriched pattern [13]. This 
repression is regulated further by TBR1 which promotes the identity of corticothalamic 
neurons occupying layer VI [25].  
Different transcriptional programs control late-born neurons residing in UL. The transition 
from generating DL to more superficial-layer neurons requires the negative feedback of post-
mitotic DL neurons themselves [26]. UL neuron identity is controlled by factors such as 
SATB2 or BRN1/2 among others [18,28,32].  
At the late stage of corticogenesis, regulatory cascades are gradually restricting the 
neurogenic potential of progenitor cells shifting it towards gliogenesis. Before this happens, 
however, basic helix-loop-helix (bHLH) genes, such as Mash1 or Ngn2 repress astrocyte fate 
[29].  
1.2 CELLULAR MICROENVIRONMENT 
From the very beginning of embryonic development, all cells exist in a bigger context of the 
microenvironment. This microenvironment will have a great impact on the cell throughout 
its lifecycle leading to different outcomes even in genetically identical cell clones. The idea 
of environment shaping the cell fate is more than 200 years old [34]; however, it was proven 
almost a hundred years later by demonstrating that cells upon implantation in different 
regions of embryos, take different paths in their later development [35,36].  
The microenvironment is a capacious term that can contain all the factors that directly or 
indirectly influence cells in a given space through physical, mechanical or biochemical 
interactions. The most commonly named factors are: the extracellular matrix (ECM), 
neighboring cells, mechanical forces, cytokines, hormones, growth factors, nutrients and 
oxygen levels. The totality of these factors, especially in the context of stem cells residing in 
them, is called the stem cell niche. Together, these components contribute to cell 
maintenance, migration, and differentiation [37–40] (Figure 2.). 
The cellular environment plays a crucial role in every stage of cell life. Starting from 
development, where secreted growth factors affect epigenetic regulation of cells resulting in 
different developmental fates [41]. At later stages, the environment can regulate self-renewal, 
apoptosis and differentiation of stem cells within the adult stem cell niche influencing tissue 
maintenance and homeostasis [37]. Finally, the microenvironment can undergo changes in 
pathogenesis and is involved in cancer formation and progression [42]. 
In developmental biology, tissue engineering and cancer research, it is essential to consider 
the microenvironment and its influence on the system of interest, whether trying to 
understand its influence in vivo or recreating it in vitro for better modeling or regenerative 
medicine applications.  
  
 
Figure 2. Stem cell niche and the microenvironment influencing cells in the body. The microenvironment surrounding 
cells is complex and dynamic: influencing cell behaviour but it is also modified by the cells. Reproduced from Lane et al. 
(2014) with permission from Springer Nature. 
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The ECM is a complex network of proteins, proteoglycans and glycosaminoglycans (GAGs), 
creating a three-dimensional scaffold for cells and comprising an essential part of their 
microenvironment. The ECM is in a constant dynamic interaction with cells, influencing 
tissue development and homeostasis. Further, the ECM has several functions such as being a 
substrate for cell attachment organizing cells in three-dimensional space and in relation to 
each other as well as facilitating the transmission of signals and providing mechanical cues 
to modify cell behavior [43–45].  
The cross-talk between cells and the ECM was described in the dynamic reciprocity model, 
which postulates that the ECM both modifies cell behavior but is also modified by cells over 
time [46]. In general, this bi-directional interplay is realized through membrane receptors 
such as integrins and/or mechanosensitive ion channels through a process called 
mechanotransduction [47]. The ECM’s unique chemical and spatial composition will create 
different biochemical and biophysical environments suitable for different cell types i.e. 
providing attachment through cell-specific receptors and providing mechanical stimulation. 
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1.2.1.1 ECM stiffness 
Every tissue can be characterized by specific mechanical properties which will result in 
different cellular responses, crucial during organ development but also its homeostasis in 
adult life. The human body displays a broad range of different elasticities that can be 
characterized by Young’s modulus (E). The brain is one of the softest tissues in our body 
(E≤4∙102 Pa) while the muscle is in the middle of the spectrum (E≥104 Pa), bone closes the 
range, being the stiffest (E≥109 Pa) [48].  
ECM stiffness has a great impact on several aspects of cellular behavior such as growth, 
survival, motility and differentiation. These responses are cell type-dependent and can have 
a different impact at different developmental stages. For example, mesenchymal stem cell 
(MSC) lineage specification can be altered depending on the substrate stiffness on which they 
are grown. Soft matrix, corresponding to brain stiffness, will result in neural differentiation, 
whereas a bone-like rigid environment will direct these cells into an osteogenic pathway, 
with myogenic differentiation on the intermediate substrates [38]. 
During mouse cortical development, tissue in all the layers undergoes significant changes in 
stiffness [49]. It was also shown, that NSCs similarly to MSCs can sense elasticity of the 
surrounding environment and respond to it with altered differentiation programs. Teixeira et 
al have shown that substrates resembling brain stiffness promote neuronal maturation of 
NSCs and increase astrocytic differentiation in vitro [44]; however, this response is likely to 
be stage dependent, as adult NSCs were found to generate more neurons and less glia cells 
in similar conditions [50]. 
1.2.1.2 Geometry of the ECM 
The geometry of a cell’s environment is another crucial parameter contributing to the cell 
niche. Cells are exposed to a dynamically changing three-dimensional (3D) world from the 
very beginning. During embryonic development monolayers of cells start to change their 
shape, transforming into early morphologies of different tissues and organs.  
The spatial organization of the ECM can be viewed at different scales, from nano- to 
microarchitecture. It has been shown that the nanostructure of the cellular microenvironment 
can have a great impact on cells. Different geometries have been shown to drive MSCs into 
various differentiation programs. When cultured on rectangular or pentagonal shaped areas, 
MSCs displayed different outcomes, favouring either osteo- or adipogenic pathways 
depending on the growth conditions. This response is mediated through differential myosin 
contractility and subsequent gene expression alterations in the MAP kinase pathway and Wnt 
signaling [51]. MSCs neuronal differentiation can also be altered by geometry itself. It has 
been shown that a higher level of nanopattern complexity (spikiness) can stimulate MSCs to 
produce higher percentages of MAP2 positive cells [52]. The substrate topography is an 
important factor influencing also other cell types. It has been shown for instance that in NSCs 
nano-roughness of the surface on which they were cultured through the mechanosensing 
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cation channel Piezo-1, induced neurogenesis, despite the conditions normally favoring 
gliogenesis, suggesting the importance of the topography for NSCs differentation [53]. 
3D context at the microscale introduces different mechanics, cell-cell/cell-matrix interactions 
as well as oxygen and nutrient diffusion [54]. The 3D nature of the environment itself is 
enough to affect cellular morphology [55] and responses. Cell attachment, proliferation and 
migration can be enhanced when given a third dimension, compared to 2D conditions on the 
ECM with the exact same composition [56].  
1.2.1.3 Attachment 
Another role of the ECM is providing attachment for cells through specific interactions 
between cell membrane receptors and protein sequences in the ECM. There are two most 
common proteins providing adhesion: laminin and fibronectin.  
Laminins exist in at least 16 different isoforms composed of a, b, and g chains in different 
configurations. Its diverse forms can mediate cell attachment and cell functions such as 
differentiation or migration [57]. Cell attachment to laminin happens through integrin 
receptors and laminin G-like domains (LG) in the C-terminal region of the long laminin arm 
[58]. In the context of NSCs, laminins were shown to play an important role in promoting 
proliferation [59,60] and differentiation [61]. 
Another integrin-related cell-ECM binding is realized through one of the most studied 
adhesive peptides: arginine-glycine-aspartate (RGD). This tri-amino acid motif is present in 
many ECM proteins such as the aforementioned fibronectin, but also vitronectin or 
fibrinogen. Many different cell types use this mode of adhesion and this fact is widely used 
for engineering materials that are designed to promote cell attachment [62]. For instance, 
vitronectin derived sequence was used to functionalise recombinant spider silk used in Paper 
IV in this thesis. 
1.2.2 Oxygen 
Stem cells also respond to the metabolic status of the tissue that they reside in. One of the 
most important components of the niche microenvironment is oxygen. In adult tissues, the 
physiological oxygen concentration is estimated to be between 2-9% [63] which constitutes 
a, so-called, normoxic condition, much lower than atmospheric levels. However, during 
development, oxygen concentration on average can be even lower (approximiately 3%) due 
to the ongoing vascularization [64]. Human stem cells exposed to reduced oxygen levels 
(approximately 5%) in culture show increased proliferation [65].  
Cells react to hypoxia mainly through hypoxia-inducible factor (HIF) family proteins. The 
HIF complex is composed of two subunits: HIF1α and HIF1β [66]. Under normoxic 
conditions, HIF1α is transported to the cytoplasm where it is proteolytically degraded [67]. 
Below 9% oxygen, HIF1α stabilizes and can dimerize with HIF1β. Upon translocation to the 
nucleus, it can transcriptionally activate genes involved in cell cycle regulation, angiogenesis 
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or glucose metabolism [68]. In the context of NSCs, hypoxia (1% oxygen) reduced cell 
differentiation into neurons upon FGF withdrawal through a Notch-mediated mechanism and 
its interaction with HIF1 [69]. It was also shown that HIF1α activation and interaction with 
the Notch signaling pathway in low oxygen environment can increase NSCs differentiation 
into astrocytes [70].  
While creating relevant in vitro microenvironments, not only global oxygen concentration is 
important, but also local effects should be considered, especially in the context of 3D 
constructs. Oxygen availability for cells in such scenario depends mainly on the oxygen 
partial pressure and diffusion rates through the biomaterial. Further from the outer edge of a 
3D construct oxygen levels can drop to suboptimal levels creating a hypoxic core [71,72]. 
1.2.3 CtBP2 
Another mechanism of how cells respond to their microenvironment is through the redox 
sensing transcription corepressors CtBP, which has two similar homologs (CtBP1 and 
CtBP2) in vertebrates.  
The center of the CtBP2 protein consists of a dimerization domain and a PLDLS-binding 
sequence which allows interactions with transcription factors. The N-terminal region in 
CtBP2 is different from that in CtBP1, as it contains a nuclear localization signal. These 
corepressor proteins have the unique property of sensing metabolic status by binding to both 
nicotinamide adenine dinucleotide (NAD+) and its reduced form NAD(H), but with higher 
affinity to the latter one, which is important for CtBP’s enzymatic activity [73,74]. Moreover, 
dinucleotide binding promotes interactions between CtBP1 and CtBP2 to form homo- and 
hetero-dimers [73], which in turn can stimulate binding to some of the CtBP target proteins 
[75]. It has also been shown that higher nuclear levels of NAD(H) induced by chemical 
hypoxia, resulted in enhanced transcriptional repression by CtBP [76]. Recent evidence 
confirms the ability of CtBP1 and CtBP2 to form tetramers, also regulated by NAD(H) 
binding; however the exact physiological role of such a complex remains to be elucidated 
[77]. 
CtBP2 mutant mouse embryos show aberrant neural development with delayed forebrain and 
midbrain formation. CtBP2-null mice embryos eventually die by E10.5, whereas CtBP1-null 
mice show a less severe outcome resulting in smaller but viable animals upon birth, that die 
earlier than wild type mice. When both proteins were knocked out, the obtained phenotype 
was the most severe with embryos not even reaching the head fold stage [78].  
The CtBP protein family is involved in oncogenesis and development controlling cell 
survival, proliferation and migration through binding to other transcription factors (over 30 
identified by now) and interactions with histone deacetylases (HDAC1, HDAC2), 
demethylases (LSD1) and histone methyltransferases (HMTs) [78,79]. Moreover, CtBPs can 
act as co-repressors by the recruitment of Polycomb proteins to DNA and interactions with 
proteins such as p300 to repress their histone acetyltransferase function [80,81]. 
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Both CtBP1 and 2 are linked to the suppression of apoptosis and the epithelial-mesenchymal 
transition (EMT) playing an important role in hypoxia-regulated E-cadherin suppression 
[82]. In addition, CtBP was found to be upregulated in different cancer cell types often linked 
with poor patient prognosis [83,84]. 
In the context of neuronal development, CtBP1 was shown to repress neuronal differentiation 
in the metabolic context of high levels of oxygen and bone morphogenic protein (BMP) in 
chick spinal cord by interaction with HES1 in a co-repression complex [85]. CtBP1 also 
interacts with the transcriptional repressor Ikaros [86] which in turn regulates the temporal 
identity of neurons in the mouse cortex during development [87]. Additionally, CtBP2 was 
found to interact with Zinc-finger E-box binding homebox 1 (ZEB1) in the mouse developing 
cortex [88]. ZEB1 is an important factor in the EMT involved in physiological and 
pathological processes such as neural crest formation or metastasis of carcinoma cells 
[42,89]. Overexpression of Zeb1 in mouse embryonic brain at E14.5 was found to block 
progression from basal radial glial cells to neurons and disrupt normal cell migration in the 
developing cortex. Overexpression of Ctbp2 in developing mouse brain in the same study 
resulted in higher percentage of immature IPs in IZ/SVZ and altered morphology of neurons 
[88]. However, there is no clear mechanism of how CtBP2 can influence neural stem cells, 
especially in the microenvironment perspective.  
1.2.4 Microenvironment in pathology 
The correct tissue microenvironment is both an indicator of and a required factor for organ 
homeostasis. However, it can undergo changes due to pathological processes, that will disrupt 
the balance that may promote disease progression and hamper potential treatment. The 
microenvironment in tumor development for example undergoes radical changes, such as 
remodeling of the ECM resulting in changes in mechanical properties. The stiffening of the 
matrix is a very common hallmark of developing tumors which was used for cancer diagnosis 
already in ancient times. The local architecture also undergoes modifications during tumor 
development: normally relaxed and randomly oriented collagen fibrils start to become thicker 
and aligned, which contributes to later metastasis [48,90].  
1.3 NEUROBLASTOMA 
Neuroblastoma (NB) is the most common (12-15% of all childhood cancers) and deadliest 
extracranial tumor in children. It originates in the sympathetic nervous system and is most 
likely derived from sympathoadrenal progenitor cells of the neural crest. NB is a highly 
heterogeneous malignancy and can be manifested in mild or severe forms, with very different 
prognoses: from up to 90% survival rates in patients diagnosed with low-risk types, down to 
only 50% in the high-risk groups. The high-risk and poor-outcome associated groups are 
often characterized by amplification of the developmental transcription factor and oncogene 
MYCN. The majority of patients demonstrate aggressive subtypes of NB, for which current 
therapies often fail. A part of the problem is a lack of successful pre-clinical models to study 
NB biology and the subsequent drug response [91]. 
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In terms of its microenvironment, NB specimens from high-risk patients were found to be 
highly fibrous with collagen I as the main ECM component [92]. Moreover, NB cells in vitro 
displayed sensitivity to the microenvironment showing different morphology and gene 
expression in response to geometry and mechanical properties of the culture matrix [93,94]. 
1.4 RECREATING STEM CELL NICHE BY 3D BIOPRINTING 
The idea of growing cells outside the human body was first introduced by Loeb in 1897 [95]. 
Since then, in vitro cell culture went a long way from just an idea to advanced technology. 
Establishing stem cell lines in 1998 [96] greatly contributed to the foundations of the tissue 
engineering field, which emerged as a “bridge” connecting research focused on whole organs 
and studies on culturing homogenous cells [97]. This combination of biology and engineering 
addresses critical problems in the treatment of tissue loss or organ failure. In spite of 
invaluable help in saving or improving countless lives, treatment based on transplantation of 
organs suffers from severe limitations such as donor shortage or immunological rejection 
[98]. Apart from application in therapeutics, tissue engineering can also be used in basic 
research to develop biomimetic in vitro tissues and organs to study physiology, toxicology, 
pathology of their natural equivalents as well as for drug testing [99–102].  
To culture stem cells in vitro, optimal conditions should be provided to mimic their natural 
microenvironment. Numerous attempts were made to imitate the stem cell niche by using 
matrix components of different stiffness, modifying cell-cell mechanical interactions, 
manufacturing nanofibrous materials or introducing three-dimensionality into cell culture  
[38,103,104].  
Conventional tissue engineering is based on manufacturing scaffolds and populating them 
homogenously with cells. This approach was successfully used for the generation of various 
tissues for clinical applications [105,106]. However, there are some limitations to traditional 
tissue engineering. One problem is the precision of controlling microarchitecture aspects of 
tissue constructs such as pore size, geometry and distribution or precise spatial location of 
cells [107,108]. Since localization of cells in tissue is crucial for proper organ formation and 
function [109] this requirement must be fulfilled for biological constructs that aim to reflect 
the in vivo situation.  
To address this need, techniques such as photolithography, soft lithography, and stamping 
can be applied for microfabrication. However, they are not free from challenges such as 
limited range of compatible materials, low speed or method complexity [110]. Another 
approach to creating biomimetic tissues or organs is to utilize cell self-organization properties 
to create organoids [111]. However, some of the organoid-based models suffer from poor 
reproducibility and challenges in size and geometry control [112].  Some of these limitations 
can be solved with the bioprinting approach.  
Bioprinting can be defined as a technology that allows the transfer of non-living materials 
such as proteins, drugs, biomaterials, ECM components and living cells to solid, gel, or liquid 
media with prescribed and precise spatial locations [113]. The very first reports of two-
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dimensional bioprinting started to appear at the end of the 1980’s [114] when a modified 
office inkjet printer was used to deposit cell adhesion proteins in predefined positions onto 
substrates. In 2003, this technology was used by Wilson and Boland to print viable cells for 
the first time [115]. But researchers did not stop only at 2D patterning. Adding the next 
dimension to printing was made possible thanks to the advancement in 3D manufacturing 
initiated by Charles W. Hull who invented a method called stereolithography in 1986. This 
technique was described as the generation of three-dimensional objects by additive 
application of fluid material that was cured by UV light in a layer-by-layer fashion [116]. In 
2004, Smith et al first applied cell extrusion based on a similar principle for 3D deposition 
of viable cells [117].  
Systems for extrusion-based printing usually have two main components: a dispensing 
system and a stage (Figure 3.). Dispensing systems are typically based on pneumatic pressure 
[118,119] or mechanical extrusion [120]. To allow material deposition in a predefined spatial 
pattern one or both components can move along the x, y and z-axis, controlled by computer 
software [121,122]. Materials are extruded continuously through the nozzle in the form of 
filament to create 2D or 3D constructs. During this process, one layer at a time can be 
deposited. Usually, in bioprinters, different hydrogels are used for extrusion. For that, the 
specific used hydrogel used must be able to flow through the nozzle in particular conditions. 
When the first layer is deposited, it can be cross-linked, thereafter another layer can be printed 
on top of it [123]. Depending on the used material, hydrogels can be cross-linked either 
physically (i.e. thermal or ionic crosslinking) or chemically [117,124,125]. Usually, high 
viscosity hydrogels are used – either with cells embedded (also called bioink) [126,127] or 
without cells [128–130].  
 
   
 
Figure 3. Microextrusion 3D bioprinting workflow overview. The 3D model is prepared using computer software and 
can be based on existing data from i.e. MRI patient scan. The 3D model is then translated into instructions for the 3D 
printer to follow. Microextrusion printing can be realized through different modalities: piston, pneumatic or screw driven. 
Cells mixed with hydrogel are deposited onto the printing platform in a layer-by-layer fashion. Such constructs can be 
later used for in vitro cell culture or implants for in vivo applications. 
However, extrusion-based bioprinting is not restricted to hydrogels. Some methods utilize 
biocompatible thermoplastic polymers for stiffer scaffold manufacturing [131] or apply 
multicellular spheroids as bioink for tissue self-assembly [132]. The multitude of the 
parameters involved in extrusion-based 3D bioprinting, such as 3D model processing, 
biomaterials, cell density, extrusion pressure, printing speed, temperature, cross-linking, 
post-processing, and cell culture conditions must be orchestrated to achieve optimal results 
in terms of cell viability and print quality.  
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1.4.1 3D bioprinted in vitro tissues 
3D bioprinting can recapitulate many aspects of the cellular microenvironment found in vivo 
for more accurate tissue modeling. With precise spatial control, bioprinters can construct 
geometries reassembling the microarchitecture of particular organs, including channels to 
mimic vascularization. Depending on the biomaterial used in the manufacturing process, 
properties such as stiffness, porosity, availability of cell-adhesion sites, and presence of 
extrinsic signals such as growth factors can be mimicked to reflect native tissue [133].  
So far, bioprinting has successfully been employed to create promising 3D models of many 
physiological tissues, such as skin, bone, cardiac tissue and liver [134–137]. However, the 
potential of bioprinting is not only limited to mimicking healthy tissues. This technology is 
also becoming more popular for the creation of biological systems that aim at recreating a 
disease microenvironment. As in healthy tissue, the complexity of the tumor 
microenvironment is rarely mimicked by simplistic 2D in vitro models failing to test drug 
efficacy [138,139]. 3D bioprinted models of glioblastoma, mammary carcinoma, lung 
carcinoma, and many others were created, showing sensitivity to chemotherapeutics, drug 
distribution dynamics or metastasis behavior closer to the in vivo environment [140–142]. 
This opens possibilities for better preclinical models and precision medicine.  
1.4.2 Biomaterials for bioprinting 
Optimal biomaterials for 3D bioprinting remain a major challenge in the field. In general, 
they can be divided into two groups: naturally derived and synthetic. Some of the most 
popular materials belonging to the first group are alginate, collagen, chitosan, gelatin, and 
hyaluronic acid.  Because of their natural origin, they provide many chemical signals for 
cells, enabling their attachment and growth. Nevertheless, naturally derived biomaterials 
often suffer from batch-to-batch variation and variable printability, which makes them 
difficult to apply to stem cell constructs, especially in a clinical context [143–146].  On the 
other hand, synthetic polymers such as poly(ethylene glycol) can provide better physical 
properties; however, they usually lack active binding sites, which results in low cell viability 
[147,148].  
1.4.2.1 Sodium alginate 
Sodium alginate (SA) is a sodium salt of alginate, a polymer naturally present in cell walls 
of brown algae (Phaeophyceae), which is its main commercial source; however, alginate can 
be also synthetized in bacteria. Alginates are a group of polymers which consist of L-
guluronate (G) and D-mannuronate (M) residues arranged in blocks. These blocks can be 
only G, only M or combination of both in a sequence [149] (Figure 4.). The content, length 
and ratio of different blocks in alginate have an impact on the polymer mechanical properties. 
Usually, the longer the G-block and the higher the molecular weight, the better the 
mechanical properties of the resulting hydrogel. It is a consequence of the fact that only G-
blocks of alginate are participating in alginate ionic crosslinking. This happens through the 
addition of divalent cations, such as Ca2+, which are coordinated by guluronate blocks that 
   
form junctions with each other to form a gel [150]. Ionic cross-linking using calcium chloride 
(CaCl2) is the most common way of creating alginate-based hydrogels, however covalent, 
cell and thermal cross-linking are alternative options.  
Biocompatibility, low toxicity and immunogenicity, cell-friendly cross-linking and low cost 
make SA a very versatile biomaterial. It found applications in wound healing, drug delivery 
and cell encapsulation for tissue engineering or cell transplantation [149]. Since the 1980s, 
when the first pancreatic islet cells were encapsulated in SA [151], this biomaterial was used 
for applications with many different cell types, such as MSCs, hepatocytes or myoblasts 
[152,153]. Immobilization of NB cells in SA microbeads was also reported [154]. It was 
shown that NB cells maintained their growth and electrophysiological activity while 
encapsulated in 3D SA hydrogel.  
SA can also be used for 3D bioprinting, however, when low viscosity sodium alginate is used, 
it presents a challenge for precise material deposition with the maintenance of accurate 3D 
geometry. Methods such as coaxial nozzle-assisted 3D bioprinting can be used to overcome 
this problem, by extruding SA and CaCl2 at the same time, causing rapid gelation [155]. 
However, applications of systems like this can be limited and an alternative might be needed. 
One of them is the freeform reversible embedding of suspended hydrogels (FRESH).  
 
Figure 4. a) Molecular structure of sodium alginate. G, L-guluronate; M, D-mannuronate  b) Interaction between the 
calcium ion and oxygen in gluronic acid.  
FRESH is a bioprinting technique that allows for controlled deposition of hydrogels with low 
viscosity, providing support during the extrusion process as well as means for cross-linking 
of the printed material. Its main component is a support bath made of blended gelatin slurry, 
that has shear-thinning properties. The needle used for bioprinting, while immersed, can be 
freely moved around inside the slurry; however, when the SA is extruded, the support bath 
keeps it in place and start its gelation with a low concentration of CaCl2. When the bioprinting 
process is done, gelatin can be dissolved in 37 °C and the 3D printed construct can be 
retrieved [156]. 
Despite being a versatile material, SA has its limitations. Hydrogel swelling, inadequate 
mechanical properties, lack of cell binding sites and printability challenges may reduce its 
application in some cases. Thus, alternative biomaterials should be considered.  
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1.4.2.2 Recombinant spider silk 
One of the alternatives to naturally derived SA is synthetic, recombinant spider silk. Spider 
silk is one of the strongest materials naturally occurring in the environment. Its mechanical 
and biological properties were noticed and utilized already centuries ago for various 
applications: from fishing through garment production to medicine. Now, we understand the 
biochemical and mechanical properties of spider silk better than ever before and its 
characteristics remain attractive for medicine, especially for tissue engineering applications.  
As spiders are territorial and it is difficult to farm them, numerous attempts were made to 
create a recombinant version to have access to larger quantities of the spider silk protein 
(spidroin) and control its composition. One of them was the production of a miniature spider 
silk protein 4RepCT in E. coli. Recombinant spider silks were found to be compatible with 
different cell type such as fibroblasts [157,158], bone marrow stromal cells [159], 
chondrocytes [160], human mesenchymal stem cells [161] and neural stem cells [162]. In 
addition to supporting cell growth in vitro, in vivo biocompatibility was also reported 
[163,164].  
To better mimic the in vivo microenvironment recombinant spider silk was also applied in 
creating 3D constructs, however, these were sponges of random porous microarchitecture 
[162,165]. To overcome this limitation, 3D bioprinting was applied resulting in 
manufacturing cell-laden macroscopic constructs made of recombinant spider silk [166]. 
However, attempts to create artificial spider silk with mechanical properties similar to the 
natural equivalent remains a bottleneck in the field. This might be explained by the fact that 
denaturing conditions are usually applied for purification and fiber formation of recombinant 
spidroins [167]. Through the study of the natural process of dragline spinning, its 
mechanisms involved in it became clearer. Recently, the molecular basis of spider silk 
formation was better understood, highlighting the importance of carbonic anhydrase that 
creates a pH gradient in silk glands enabling proteins to polymerize [168]. Thus, it was 
suggested that the combination of recombinant spider silk with the right structure and low 
pH conditions, using an extrusion system (i.e. microfluidics device) could be a much better 
way of creating artificial spider silk [167]. A similar approach could be applied in a 3D 
bioprinting microextrusion system that additionally would give the advantage of spatially 
controlling the microarchitecture of the 3D construct.  
Recently synthesized recombinant spider silk NT2RepCT that couples favorable mechanical 
properties with biomimetic spinning potential resulted in the toughest as-spun fibers thus far. 
The synthetic character of this spidroin allows for the introduction of additional cell 
attachment motifs such as RGD or IKVAV to better mimic the cellular microenvironment  
[159,169]. However, the exact cytocompatibility of the material and its effect on different 
cell types is not known yet. Thus, before fully realizing its potential, more studies have to be 
done. 
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2 AIMS OF THE THESIS 
The general aim of this thesis was to investigate how microenvironment can affect and be 
translated to neural stem cells and what tools can be used to engineer microenvironment in 
in vitro cell culture.  
The specific aims of the scientific papers included herein are to: 
I. Investigate how the redox-sensitive CtBP2 protein influences cortical neurogenesis. 
II. How different metabolic conditions affect CtBP2 acetylation and oligomerization 
status in rat neural stem cells in vitro. 
III. Optimize the 3D bioprinting method to engineer a three-dimensional 
microenvironment for in vitro cell culture of human neuroblastoma cells. 
IV. Assess the cytocompatibility of recombinant spider silk with human neural stem 
cells. 
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All animal experiments included in this thesis were conducted in compliance with the 
guidelines of the Swedish Board of Agriculture (ethical permits N284/11, N190/14 N329/11, 
N217/14) and were approved by the Karolinska Institutet Animal Care Committee. 
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In utero electroporation (Figure 5.) was performed as described elsewhere [170] with some 
modifications. Mouse embryos (E15) were injected with two siRNA constructs: control or 
CtBP2 (Dharmacon/Accell), along with GFP plasmid at a 1:3 ratio and Fas Green into the 
lateral ventricle. The electroporation (CUY21 EDIT, TR Tech, Japan) used five 50V pulses 
at 50 ms with 950 ms breaks. Three days after electroporation, E18 embryos were recovered 
and sacrificed for brain collection.  
 
Figure 5. Overview of the in utero electroporation. At E15, the uterine horn is exposed during the surgery, mouse 
embryos are injected with siRNA constructs and GFP plasmid into the ventricle. Voltage is applied to deliver the construct 
to the cells. Mouse embryos are then sacrificed at E18 for sectioning, immunostaining and analysis.   
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E18 mouse brains were fixed using 4% PFA for 2 days at 4 °C. Next, they were immersed in 
30% sucrose solution for 4-7 days. Samples were mounted in TissueTek for cryostat 
sectioning at 18 µm slice thickness. Later, the slides were preserved at -80 °C. 
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Slides with E18 mouse cortex sections were rehydrated with 1X PBS for 5 minutes and 
subsequently permeabilized and blocked with 10% Normal Donkey Serum (NDS, Jackosn 
Immunoresearch) and 0.3% Triton x-100 in PBS for 1 hour at room temperature. Incubation 
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with primary antibodies (Table 1) at a 1:200 ratio was carried over-night at room temperature. 
Then, slides were washed 2x in PBS for 10 minutes. Incubations with secondary antibodies 
were carried for 1 hour at room temperature using 1:500 dilution. Next, samples were washed 
in PBS and incubated with DAPI/PBS solution (1:2000) for 1 minute, with subsequent 
washing in PBS for 2 minutes. Lastly, the slides were mounted using Vectashield medium.  
 
Table 1. Primary antibodies used for immunocyto-, histochemistry, and PLA. RT, room temperature; ON, over night.  
Antibody name Host Species 
Manufacturer and 
number Concentration Dilution Temperature Time 
GFP chicken Aves (GFP-1010) 10 mg/ml 1:200 RT ON 
TUJ1 mouse Biolegend (801202) 1.0 mg/ml 1:200 RT ON 
Nestin goat Neuromics (GT15114) 1.0 mg/ml 1:200 RT ON 
Ki67 rabbit Abcam (ab15580) 1.0 mg/ml 1:200 RT ON 
PAX6 mouse Covance (PRB-278P) 2.0 mg/ml 1:200 RT ON 
TBR2 rabbit  Abcam 0.7 mg/ml 1:200 RT ON 
CUX1 mouse Abnova (521-620) 1.0 mg/ml 1:200 RT ON 
CTIP2 rat Abcam (ab1846) 1.0 mg/ml 1:200 RT ON 
SATB2 mouse Abcam 0.1 mg/ml 1:200 RT ON 
SOX9 goat R&D Biosystems,(AF3075) 1.0 mg/ml 1:200 RT ON 
CtBP2 
(immunohistochemistry) rabbit Abcam (ab96107) 0.33 mg/ml 1:200 RT ON 
CtBP2 (PLA) rabbit Abcam (ab128871) 0.5 mg/ml 1:200 37 °C 1h 
CtBP2 (PLA) mouse BD Biosciences (612044) 0.25 mg/ml 1:200 37 °C 1h 
SIRT1 rabbit Santa Cruz (sc-15404) 0.2 mg/ml 1:50 37 °C 1h 
pan-acetylated 
lysine rabbit Cell Signaling (9441) 1.0 mg/ml 1:200 37 °C 1h 
p53 mouse Cell Signaling (2524) 1.0 mg/ml 1:200 37 °C 1h 
Vinculin mouse Sigma N/A 1:100 37 °C 2h 
 
3.4.2 Fluorescent staining of NESCs 
NESCs were fixed using 4% PFA solution for 15 minutes at room temperature, then washed 
2x in PBS for 5 minutes. Cells were permeabilized and blocked in 1% Bovine Serum 
Albumin (BSA, Sigma), 0.1% Triton x-100 for 30 minutes at room temperature.  
Fixed samples were incubated with Alexa Fluor 488 Phalloidin (Thermo Fisher) diluted in 
PBS at 1:100 ratio for 1 hour at room temperature or primary antibody against vinculin (1:100 
dilution in blocking solution) for 2h at room temperature (Table 1). Next, slides were washed 
3x in PBS for 5 minutes. Samples incubated with anti-vinculin antibody were then incubated 
with secondary antibody (Alexa fluorophore 594, Thermo Fisher, 1:500 dilution in PBS) for 
1 hour at room temperature. After that, samples were washed in PBS and mounted using a 
mounting medium with DAPI.  
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Proximity Ligation Assay (Figure 6.) kit (DuoLink/Sigma) was used on fixed and 
permeabilized NSCs using 4% PFA for 10 minutes and 0.1% Triton x-100 for 15 minutes. 
Next, samples were blocked using Blocking Solution (DuoLink) for 30 minutes at 37 °C. The 
primary antibodies used for PLA are described in Table 1. The overlapping C-terminal region 
was used for two different antibodies against CtBP2 for dimer detection. After the incubation, 
samples were washed 2x in Wash A solution included in the PLA kit, 5 minutes each. Next, 
detection probes were applied for 1 hour at 37 °C with subsequent 2x washing with Wash A. 
Ligation (30 minutes, 37 °C), 2x washing with Wash A, amplification (100 minutes, 37 °C), 
2x washing with Wash B were carried in a sequence. For counterstaining, Alexa 488-
Phalloidin (Molecular Probes) was applied. In the end, samples were mounted in DuoLink 
mounting medium.  
 
Figure 6. Schematic overview of the PLA method principle. 
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The live/dead assay (Life Technologies) for SKN-BE(2) cells was performed according to 
the manufacturer's instruction with minor modifications using 4 µM EtD and 2 µM calcein. 
For washing, DMEM/F12 media was used instead of PBS to prevent scaffold dissolution. 
For NESCs, 0.5 µM EtD and 0.2 µM calcein were used with a standard PBS washing. 
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3.4.5 EdU assay 
The Click-iT EdU Alexa Fluor 594 kit (ThermoFisher) was used for detection of proliferating 
NESCs. 10 µM of EdU diluted in culture media was incubated with cells for 1 hour at 24 and 
72h time points. Cells were then washed in PBS and fixed using 4% PFA for 15 minutes, 
followed by 3x washing 5 minutes each. The signal detection was carried out using EdU 
detection at room temperature for 30 minutes. Cell nuclei were stained using Hoechst. 
Samples were mounted in mounting media (Vectashield). 
3.5 IMAGE ACQUISITION 
The different samples were imaged with Zeiss LSM 700 confocal microscope, Operetta High 
Content Imaging system or Zeiss Observer Z1 inverted microscope and analyzed in ImageJ, 
Imaris or Harmony software.  
3.6 CELL CULTURE 
3.6.1 Rat NSCs 
The developing cortex was isolated from E15.5 rat embryos and dissociated into single cells 
that were seeded in DMEM/F12 media supplemented with penicillin/streptomycin and 
modified N2 containing additional insulin. FGF2 (10 ng/ml) was added daily. Culture plates 
were coated using poly-l-ornithine and fibronectin solutions. Cells were cultured at 37 °C, 
5% CO2 and upon confluency, NSCs were split using HANKS solution. Only passage 1 and 
2 were used for experiments.  
For metabolic treatments, NSCs were either incubated in a hypoxia chamber (1% oxygen) or 
in normoxia with the addition of 5 mM 2DG (Sigma) overnight. Sirt1 inhibition was achieved 
using 1 mM Ex527 (Tocris). H2O2 treatment was conducted for 30 minutes or 1 hour using 
500 µM solution.  
3.6.2 SKN-BE(2) 
SKN-BE(2) cells (ATCC, CRL-2271) NB cells were cultured at 37 °C, 5% CO2 in 
DMEM/F12 culture media  (Life Technologies) with 10% Fetal Bovine Serum (FBS, Sigma)  
and 0.1 mg/ml penicillin/streptomycin (Life Technologies). Every three days, culture media 
was replaced and when cells reached confluency, they were split using TrypLE (Life 
Technologies).  
3.6.3 NESCs 
Human iPSC derived neuroepithelial-like stem cells (NESCs) were maintained on plates 
coated with 20 mg/ml of poly-l-ornithine (Sigma) and 2 mg/ml of laminin (Sigma). Culture 
media consisted of DMEM/F12 with GlutaMAX (Gibco) supplemented with N2 (1:100, 
Gibco), 10 ng/ml rhFGF basic (R&D systems), 10 ng/mL rhEGF (R&D systems), B-27 
supplement (1:1000, Gibco) and Penicillin/Streptomycin (Gibco). NESCs were passaged at 
1:3 ratio every 2-3 days using TrypLE Express (Gibco) and trypsin inhibitor (Gibco). For 
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NESCs culture on spider silk or vitronectin coatings, cells were passaged at 4.375×104 
cells/cm2 to a P35 dish.  
3.7 IMMUNOBLOTTING 
The Bio-Rad Mini-Protean 3 system was used for immunoblotting. Electrophoresis and 
transfer performed according to the manufacturer's protocols. 30 mg of protein was loaded 
per well. The nitrocellulose membranes were blocked and later probed with LI–COR 
reagents. The Odyssey infra-red system was used for visualization. The following antibodies 
were used for western blot: CtBP2 (Abcam, 1:2000), SIRT1 (Santa Cruz, 1:100), Beta-actin 
(Sigma, 1:4000). 
3.8 SIRNA-MEDIATED KNOCKDOWN 
CtBP2 and Sirt1 (Dharmacon) siRNA were delivered to NSCs by the Amaxa Nucleofection 
kit (Lonza). After nucleofection, NSCs were seeded in 35 mm plates in standard culturing 
conditions described above. 
3.9 BIOMATERIALS 
3.9.1 Sodium alginate 
SA was prepared by dissolving 20 mg/ml SA (Allevi) in SK-N-BE(2) culture media. 
Additionally, for the POI experiments green fluorescent PLGA microspheres (Sigma) were 
added to SA at 4 mg/ml. For bioprinting with SKN-BE(2) cells, 2% SA was mixed with cells 
at 1⋅107/ml. 
3.9.2 Recombinant spider silk 
VN-NT2RepCT protein was produced as described before [13] with modification of 
introducing the VN motif: MGPNSPQVTRGDVFTLP. The VN-NT2RepCT construct was 
cloned using a pT7 plasmid in E. coli. Bacteria culture was carried overnight in Luria broth 
(LB) media with supplementation of kanamycin (70 mg/l) at 200 r.p.m shaking. 500 ml of 
LB media was then inoculated with culture from the previous step (1/100) and incubated at 
30°C until reaching OD600 = 0.8. Then, to express the protein, the culture temperature was 
lowered to 20 °C and 0.3 mM isopropyl thiogalactoside was added. After overnight 
incubation, cells were collected by centrifugation at 5000 r.p.m. at 4 °C. Cell pellets were 
resuspended in 20 mM Tris buffer at pH = 8 and frozen at -20 °C, then lysed with a cell 
disrupter (T-S Series Machine, Constant Systems Limited) at 30 kPsi. Centrifuged lysate (30 
minutes, 27000 g at 4°C) was loaded on a Ni-NTA column and protein was eluted with 300 
mM imidazole. Protein extract was then dialyzed against 20 mM Tris buffer at 4 °C using a 
membrane with a molecular cut-off of 6-8 kDA. Finally, the product was concentrated using 
centrifugal filters (Vivaspin 20, GE Healthcare) at 4000g.  
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3.9.2.1 Cell culture plates coating 
35 mm culture plates (Corning) were coated with VN-NT2RepCT, poly-l-ornithine/laminin 
and vitronectin. VN-NT2RepCT coating was achieved using two protein concentrations: 0.1 
mg/ml and 1 mg/ml diluted in 20 mM HEPES/MES buffer (pH = 7.4), 20 mM TRIS buffer 
(pH = 8.15) and 2.5 mg/ml Glucono-delta-lactone (GDL). The coating was carried out over-
night at 37 °C with subsequent plate sterilization using UV light. Control plates were coated 
using 20 mg/mL of poly-l-ornithine (Sigma) for 2 hours at 37 °C and second coating with 2 
mg/mL of Laminin (Sigma) over-night at 37 °C. Vitronectin (Sigma) coating was carried out 
at 37 °C for 2 hours using 4.5 mg/ml of protein solution.  
3.10 BIOPRINTING 
3.10.1 FRESH preparation 
40 mg/ml of gelatin was combined with 0.16 mg/ml of CaCl2 and dissolved together in 
deionized water at 40 °C following an overnight incubation at 4 °C. A container with cooled 
gelatin was filled with a cold solution of 0.16 mg/ml CaCl2 and blended in three 30-second 
pulses followed by 30-second breaks. The resulting gel was centrifuged for 2 minutes at 4000 
RPM at 4 °C and after removal of the supernatant, gelatin was resuspended again in a cold 
0.16 mg/ml CaCl2 solution. Centrifugation and resuspension steps were repeated 3-4 times. 
Before printing, the slurry was spun down at 4 °C and 1100 RPM for 5 minutes and used for 
filling the printing container.  
3.10.2 3D bioprinting  
FRESH bioprinting (Figure 7.) was carried out using the Allevi 2 bioprinter (Allevi). 10 ml 
syringes (BD Biosciences) were filled with printing material and capped using a 2,54 cm 
long 30G blunt needle (Allevi). Four different pressures (5, 7.5, 10, 12.5 psi) and four 
different speeds (2, 4, 6, 8 mm/s) were used for extrusion of the material following gcode 
instructions. For FRESH slurry dissolution and crosslinking, 100 mM CaCl2 solution was 
added to the printing container and incubated at 37 °C for 20 minutes. Next, dissolved gelatin 
was replaced with a fresh solution of CaCl2 and incubation was continued for another 15 
minutes.  
 
 
Figure 7. Schematic overview of FRESH bioprinting and downstream analysis performed in Paper III. 
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3.10.3 Determination of the Parameter Optimization Index (POI) 
For SA visualization 4 mg/ml of green fluorescent PLGA microspheres (Sigma) were added 
to the printed hydrogel. Printed lines were imaged using Zeiss Observer Z1 inverted 
fluorescent microscope. Line width analysis was carried out using ImageJ software and 
custom-written script. POI calculations were done using formulas described elsewhere [171]. 
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4 RESULTS & DISCUSSION 
4.1 PAPER I 
CtBP2 is an important co-repressor required for proper embryonic development. Double 
knock-out of Ctbp2 in mice results in neuronal aberrations during development that result in 
embryos not surviving beyond embryonic day 10.5 (E) [78]. With previous insights from our 
laboratory into CtBPs role in the regulation of NSCs in spinal cord development [85], we 
decided to investigate the involvement of CtBP2 in cortex formation.  
First, CtBP2 protein expression pattern was analyzed. It was previously shown that CtBP2 is 
expressed in both developing and adult brain [172,173], however we looked more closely 
into its colocalization with other markers at several different time points. We demonstrated 
that CtBP2 is widely expressed at all analyzed stages of embryonic development in the mouse 
brain, namely E13, E16 and E18. Immunocytochemistry exhibited CtBP2 protein localization 
in neural progenitor cells (Nestin positive) and neurons (Tuj1 positive) through all the layers 
of the developing cortex.  
Upon successful knockdown of Ctbp2 in E15 mice brains using siRNA and GFP vector 
delivered by in utero electroporation, we observed a different morphology of the analyzed 
brains 3 days later (E18).  
Our first result indicated that in the Ctbp2 knockdown group, cells that received Ctbp2 siRNA 
together with GFP accumulated in the SVZ and IZ region. GFP+ cells in mice brains 
electroporated with control siRNA and GFP vector migrated to a large extent from SVZ/VZ 
to IZ and/or CP, demonstrating a more typical pattern of cell distribution. This accumulation 
of cells was a significant deviation compared to controls, with over twice as many GFP+ cells 
residing in the SVZ/VZ of the Ctbp2 knockdown brains.  
This result was further investigated by analysis of proliferating cells using Ki67 staining (a 
marker of the active phases of mitosis). Over 50% decrease of Ki67 GFP+ cells was found 
in the VZ/SVZ of Ctbp2 knockdown brains, compared to controls. The difference in 
percentage of Ki67 GFP+ cells in other brain regions was not significant. These two results 
together, show that CtBP2 is important for NSCs proliferation, but also that it regulates the 
NSC migration to higher regions of the developing brain (IZ, CP). CtBP2 was previously 
reported to be involved in the regulation of proliferation in cancer cells [174,175], however 
our results link it also with neuronal development and proliferation of NSCs.  
To understand the consequences of the Ctbp2 knockdown in NSCs and its impact on 
neurogenesis, brain samples were immunostained for radial glia and intermediate neural 
precursor markers PAX6 and TBR2. Both populations of cells decreased by half in Ctbp2 
knockdown group when analyzed as a proportion of GFP+ cells. In the developing brain, 
PAX6 neural progenitors give rise to TBR2+ cells, that later differentiate into excitatory 
cortical neurons [176,177]. Disruption of this sequential pattern by Ctbp2 knockdown 
suggest that it is important for maintenance of the NSC pool and proper differentiation. It 
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was previously presented that Ctbp2 knockdown in a neural crest in vitro culture can lead to 
altered differentiation, with less neuronal cells and altered regulation of Wnt pathway related 
genes [178].  
To validate this result, we also investigated the cellular composition of different cortical 
layers in the developing brain. Upon Ctbp2 knockdown, the population of GFP+ upper layers 
neurons, characterized by SATB2 [179], decreased by one-third compared to control. 
Simultaneously, no CUX1+ cells, normally representative for upper cortical layers, were 
found in treated brains among the cells with Ctbp2 knockdown. CtBP2 was previously shown 
to regulate cell migration in cancer cells [82,180] and since newborn neurons need to undergo 
migration for their maturation [181], disrupted cortical layer formation found by us suggests 
a role of CtBP2 also in migration regulation. This is further evident in recent studies of 
overexpression of Ctbp2 in developing mouse brain that exhibit disrupted neuronal migration 
patterns with cells accumulating in IZ, strengthening our hypothesis [88].  
CtBP2 is well known to be sensitive to the metabolic state of the surrounding 
microenvironment, through increased affinity to NAD(H), which is normally built up in 
hypoxic conditions [73,74]. Previous studies from our laboratory also suggest that CtBPs can 
integrate high oxygen and BMP levels to regulate NSCs state in the developing spinal cord. 
Moreover, it is being increasingly recognized, that oxygen levels and metabolism have an 
impact on NSCs and proper brain development [182]. This suggests, a possibility of CtBP2 
involvement in metabolism sensing (for example different oxygen levels due to proximity of 
progenitor cells to blood vessels [183]) and translation to NSCs fate regulation.  
4.2 PAPER II  
This study took a closer look at CtBP2 function in vitro using NSCs derived from embryonic 
rat cortex. We focused on CtBP2 acetylation, an important aspect of its enzymatic activity 
and a factor influencing its dimerization. This acetylation is mediated by histone 
acetyltransferase (HAT) p300 [184]. Moreover, many proteins acetylated by p300 are 
deacetylated by SIRT1, an HDAC class III [185]. This fact is of even more importance 
knowing that SIRT1 can also, just like CtBP2, be regulated by NAD/NAD(H) ratio and was 
shown to suppress proliferation of neuronal progenitor cells shifting their differentiation 
towards the astroglial lineage [186].  
Using a proximity ligation assay (PLA), we were able to show that CtBP2 and SIRT1 are 
found in close proximity in proliferating NSCs. PLA can detect protein-protein interactions 
if they are within 40 nm to each other [187], thus the signal detected can mean direct CtBP2-
SIRT1 binding or presence in the same, bigger complex.  
Since CtBP2 can respond to oxygen levels, and NAD(H) binding can influence its 
dimerization and activity, we looked at how different metabolic conditions can influence 
CtBP2 acetylation status in NSCs in vitro. One condition was a culture at 1% oxygen, a 
hypoxic environment which increased NAD(H) cellular levels. The second treatment was 
addition of 2-Deoxy-D-glucose (2DG), a glycolysis inhibitor, that turns down the 
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NAD(H)/NAD ratio. In both cases, CtBP2 acetylation levels increased by approximately 
50%, as assessed with PLA, compared to control normoxic cell culture (21% oxygen). 
However, the interaction between CtBP2 and SIRT1 in different metabolic treatments did 
not change. Since it was previously shown that hypoxia and 2DG can alter SIRT1 activity 
[188], we speculated that acetylation changes in CtBP2 in different metabolic conditions 
could be an effect of interaction of these two proteins. However, treatment with Ex527, a 
SIRT1 inhibitor, did not change CtBP2 acetylation status, indicating that metabolic-
dependent acetylation of CtBP2 is independent of SIRT1.  
Following the investigation of how CtBP2 is influenced by metabolism, we checked 
homodimerization of CtBP2 under hypoxia and 2DG treatment. We observed decreased PLA 
signal for CtBP2 dimers in 1% oxygen environment in NSCs. This finding contrasts previous 
reports showing a positive correlation between NAD(H) levels and homodimerization of 
CtBP2 [189], however PLA result has to be viewed as a signal drop, that can effectively mean 
either decrease in homodimerization or shift towards higher level of oligomerization, such as 
formation of tetramers. In light of recent findings that CtBP2 can form tetramers in the 
presence of high NAD(H) levels, the latter option seems highly possible [77].  
Results from paper I and II together show the importance of CtBP2 in the regulation of NSCs 
and the impact that metabolic conditions have on CtBP2. More investigation would be 
necessary to find direct links between CtBP2’s role in translating oxygen levels into NSCs 
maintenance and differentiation in the developing cortex, however these results show CtBP2 
as a potential candidate in this scenario. Paper II is also an important lesson, how an in vitro 
created microenvironment can influence molecular aspects of NSCs culture and it should be 
considered when correct stimulation is to be modeled.  
4.3 PAPER III 
Previous papers looked at the NSCs in their in vivo or in vitro environments. In paper III, the 
focus was on creating a microenvironment for human NB (SKN-BE(2)) 3D cell culture using 
the bioprinting technique. A substantial amount of evidence shows that cell culture in general 
and in particular cancer models can benefit from 3D modeling in vitro. Cell viability, 
proliferation, migration, gene expression, drug metabolism and many other aspects can often 
be mimicked better in 3D [190]. One approach to engineer such a microenvironment is by 
applying a 3D bioprinting technique. However, before printing a successful cancer model, 
which can reflect tumor biology accurately, several aspects of the manufacturing process 
should be optimized.  
Printing NB cells in a soft matrix, such as 2% SA, may be beneficial for more in vivo-like 
gene expression [93]; however, it is a challenge on its own. To make it possible, we used a 
bioprinting technique with support material, called FRESH. To achieve the best printability 
and the lowest theoretical shear stress (TSS), that can be harmful to cells, a Parameter 
Optimization Index (POI) [171] assessment was performed for different printing speeds and 
extrusion pressures.  
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Our results confirmed that 2% SA is a suitable substrate for NB encapsulation. This 
biomaterial was previously reported to be compatible with murine NB cells [154,191], 
however we used a human cell line in our study, for a translational focus.  
While printing 2% SA using the FRESH technique and a range of different parameters, such 
as speed (2, 4, 6, 8 mm/s) and pressure (5, 7.5, 10, 12.5 psi), we evaluated the width of the 
printed lines, to find the most optimal settings. This data was used to calculate a normalised 
POI value, which when closer to 1 reflects a better set of parameters. We compared POI for 
printing 2% SA alone or with a high concentration of SKN-BE(2) cells (106 cells/ml), and 
we observed significant differences in the printed line width while using the same extrusion 
conditions. This translated directly into 3D construct durability in the liquid media. It was 
previously shown, that cells encapsulated in a hydrogel precursor can affect its mechanical 
properties [192] and here we also presented how this factor influences the material 
printability.  
The highest POI for printing 2% SA with SKN-BE(2) cells was achieved at 7.5 psi extrusion 
pressure and 8mm/s printing speed. Based on the original POI findings by Webb and Doyle, 
we expected this set of parameters to be optimal for printing the cells in terms of print quality 
and cell viability [171]. However, based on a live/dead assay, we observed that at 24h post-
printing significantly more viable cells are found in prints exposed to higher pressure (12.5 
psi, 52% viable cells) than in the 7.5 psi group (19% live cells). This finding was in contrast 
to our hypothesis, that lower POI with higher TSS will result in decreased cell viability. The 
negative impact of extrusion pressure on cell viability was previously reported [119,193]. 
The reverse correlation found by us could be contributed to the fact that we used low 
pressures (5-12.5 psi) for the extrusion, whereas other reports show impact on viability 
between larger pressure differences (i.e. 5 vs 20 psi). It is also possible that more cells 
extruded with higher pressure (keeping the same cell density) resulted in increased cell 
aggregation that had a protective role increasing overall viability [194]. When cultured for 7 
days, SKN-BE(2) cells recovered from initially low viability (52% vs 83% of viable cells 
after 24h and 7d respectively).  
The final observation is related to the 3D bioprinted construct integrity when using different 
printing parameters. The set of parameters from the highest POI for printing 2% SA with 
SKN-BE(2) cells resulted in constructs that dissolved easily during prolonged cell culture. 
Thin lines might be desired for fine detail printing, however they may compromise integrity 
of the final product. Inclusion of the cells in the hydrogel can impact the local 
microenvironment via proliferation, migration and ECM remodeling [195].  
In conclusion, paper III shows  successful 3D bioprinting of human NB cells using the 
FRESH technique and broadens the perspective of using quantitative printing optimization 
methods, such as POI, taking into consideration cellular loading of the hydrogels and long-
term cell culture. Results of the paper III can extend beyond NB printing and be applied to 
creating microenvironments for other cell types, including NSCs.  
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4.4 PAPER IV  
Sodium alginate used in Paper III was a sufficient biomaterial for NB cell culture, however, 
when superior mechanical properties or addition of cell binding motifs are needed, some 
alternatives might be preferable. Therefore, paper IV focuses on cytocompatibility of 
recombinant spider silk modified with vitronectin adhesion peptide, VN-NT2RepCT, with 
human iPSC-derived neuroepithelial-like stem cells (NESCs). This particular version of 
spider silk protein has an advantage of being xeno-free and a mechanically robust material 
that has the potential to be patterned in 3D using a process mimicking natural spider web 
weaving [196].  
Initially, unmodified NT2RepCT protein was used for the culture of NESCs cells. However, 
we did not observe any cell attachment to the substrate. Since previous reports showed 
vitronectin addition to the recombinant spider silk as an effective modification enhancing 
attachment of human pluripotent stem cells [197], we applied that to the NT2RepCT protein 
tested here.  
To asses vitronectin-modified spider silk (VN-NT2RepCT) performance as a substrate for 
NESCs culture, we compared it to the current standard double coating: poly-l-
ornithine/laminin. Additionally, we used vitronectin alone as an additional control. Two 
concentrations of VN-NT2RepCT were used for culture plates coating: 0.1 and 1 mg/ml. The 
cells were grown for up to 72h and their viability, proliferation and cytoskeleton were studied.  
NESCs grown in all of these conditions displayed high viability (over 90%) when assessed 
with live/dead assay. Similarly, proliferation rates confirmed with EdU staining were typical 
for NESCs and oscillated around 30% on all substrates. This confirmed that VN-NT2RepCT 
can support NESCs attachment, survival and proliferation for in vitro cell culture and that 
this biomaterial matches its performance with current standard coating: laminin.  
When the cell morphology and cytoskeleton was examined in different culture environments, 
we observed a more stretched morphology of NESCs grown on spider silk and vitronectin 
coated plates. F-actin staining revealed more organized and elongated fibers on these 
substrates compared to laminin coating. Additional vinculin staining revealed a significantly 
higher percentage of cells with positive vinculin staining for vitronectin (77%), 0.1 mg/ml 
VN-NT2RepCT (84%), 1 mg/ml VN-NT2RepCT (88%) compared to laminin (35%). 
Moreover, vinculin morphology itself appeared to be more elongated for spider silk coatings 
in both concentrations than in pure vitronectin group, suggesting the presence of different 
forces involved in cellular attachment on different substrates. Vinculin is an actin-binding 
protein that is involved in FA formation, an important step in cell linkage to its substrate 
[198]. When its expression was abolished in mouse embryos, it led to brain development 
defects and embryonic lethality [199]. FA number and size were also found to be reduced in 
olfactory neurosphere-derived cells from schizophrenia patients, suggesting its implication 
in pathological processes [200]. Thus, differences in vinculin expression and morphology 
may have important significance in NESCs biology that should be investigated further. 
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Paper IV lays a foundation for the future application of VN-NT2RepCT in NESCs culture. 
Its mechanical properties and origin from the heterologous host (Escherichia coli) make this 
particular protein a very attractive candidate both for in vitro research but also for clinical 
applications. Moreover, NT2RepCT was designed to be able to recapitulate the natural spider 
silk spinning process using shear forces and low pH buffers and was shown to form fibers 
using a microfluidic device [196]. This property could be potentially exploited to use VN-
NT2RepCT as a biomaterial for scaffold manufacturing using a 3D bioprinting process for 
NESCs culture to better mimic their natural microenvironment.  
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5 CONCLUSIONS 
To paraphrase the English poet John Donne: “no cell is an island”. Naturally, cells  do not 
exist in isolation from each other or the surrounding world. The cellular microcosmos is not 
a vacuum deprived of stimuli, it is quite the opposite: filled with neighbouring cells, 
biochemical factors and mechanical forces. Their influence is well recognized by now and it 
is a foundation to several fields such as mechanobiology or tissue engineering. However, we 
only start to understand the importance of the tissue microenvironment for physiology and 
pathology and our ability to model it in vitro is still in the early stage.  
The work presented here, even though focuses on a small fragment of the big picture, it 
contributes to our understanding how the microenvironment may influence NSCs, what 
possible mechanisms are behind it and further looks into which tools can be applied to 
engineer the microenvironment for laboratory research.  
We have shown the significance of CtBP2, a redox-sensing co-repressor protein in cortical 
neurodevelopment. By knocking it down in the developing mouse brain, we observed a 
defective phenotype suggesting a significant role that CtBP2 plays in NSCs differentiation 
and migration. An investigation of the protein itself revealed microenvironmental cues that 
regulate its post-translational modifications in neural stem cells in vitro. This gives us an 
important base for further studies to investigate if and how CtBP2 could translate the redox 
status of the cells to their regulation in the developing brain.  
We have also validated and improved a 3D bioprinting optimization method suitable for the 
deposition of soft hydrogels and live cells. A 3D bioprinted model of NB showing good 
viability over prolonged cell culture can serve as a tool for more investigation in its biology, 
however our findings can be translated to other cell types as well. This opens up possibilities 
of co-printing NB with other relevant cell types (for example cells of the immune system) or 
other models of healthy tissues. Our approach may also be applied to other biomaterials. To 
initiate studies in this regard, we investigated the cytocompatibility of recombinant spider 
silk with NESCs cells. We have shown that this new recombinant protein supports growth 
and proliferation of human-derived neural stem cells. We have also gained insights into cell 
attachment to the substrate of interest, an important and interesting observation of different 
cytoskeletal arrangement that can potentially influence cell behavior. More studies will be 
necessary to investigate its functional aspect.  
By showing the cytocompatibility of VN-NT2RepCT with NESCs, we confirmed the 
possibility of using this biomaterial for 2D cell culture, but our results also suggest a potential 
application of recombinant spider silk as a substrate for creating 3D scaffolds for modeling 
NESCs to a prescribed geometry.  
No cell is an island, and as the oceans are the least explored environments on our planet, the 
sea of influences and archipelago of interdependencies in the cellular world remain to be 
conquered.   
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